<p><strong>Psyence Biomedical Ltd</strong> (NASDAQ: PBM) 的股票在周二下跌超过 12%，这是在周一大幅上涨后的急剧回调。投资者似乎在进行获利了结，因为该股票最近经历了垂直攀升。</p>
<p>该股票在周一的常规交易时段上涨了近 72.63%。当时，迷幻药行业获得了重大提振。</p>
<p><strong>唐纳德·特朗普</strong> 总统签署了一项行政命令，以加速 精神疾病治疗。该命令特别针对迷幻药的快速审查，并包括对伊博加因研究的 5000 万美元承诺。</p>
<h2>伊博加因供应链优势</h2>
<p>Psyence Biomedical 因其符合 GMP 标准的伊博加因平台而脱颖而出。通过 PsyLabs，该公司在非洲管理原料采购、提取和纯化。Psyence 自我定位为一个稀有的工具和设备供应商。该公司目前已持有稳定的药品级伊博加因剂量。</p>
<h2>Psyence 技术分析</h2>
<p>PBM 正在从 2 月份的低点反弹，但仍远低于其 52 周高点。该股票交易价格比其 20 日简单移动平均线 (SMA) 高出 224.7%，比其 100 日 SMA 高出 130.7%。</p>
<p>相对强弱指数 (RSI) 为 96.18，是一个动量指标。</p>
<p>从更长的时间来看，该股票在过去 12 个月内下跌了 43.93%，尽管最近上涨，但整体市场仍显脆弱。</p>
<ul>
<li><strong>关键阻力位</strong>：$12.50</li>
<li><strong>关键支撑位</strong>：$10</li>
</ul>
<p><strong>PBM 股票价格动态</strong>：根据 Benzinga Pro 数据，Psyence Biomedical 的股票在周二盘前交易中下跌 3.54%，报$10.90。</p>
<p><em>图片来源：solarseven on Shutterstock.com</em></p>

动态生物技术与基因组 ETF - Invesco

纽交所高增长板生物技术指数 ETF - First Trust

<p>Psyence Biomedical Ltd (NASDAQ:PBM) 的股价在周二下跌超过 12%，此前在周一因特朗普总统签署行政命令加快精神疾病治疗以及对伊博加因研究承诺 5000 万美元而上涨近 72.63%。投资者在上涨后选择获利了结。尽管近期有所上涨，该股在过去一年仍下跌 43.93%，在盘前交易中报 10.90 美元，关键阻力位为 12.50 美元，支撑位为 10 美元</p>

<p><strong>Psyence Biomedical Ltd</strong> (NASDAQ: PBM) shares are trading lower on Tuesday by more than 12%, a sharp reversal after a massive rally on Monday. Investors appear to be engaging in profit-taking after the stock’s recent vertical climb.</p>
<div class="lb-trans"><p><strong>Psyence Biomedical Ltd</strong> (NASDAQ: PBM) 的股票在周二下跌超过 12%，这是在周一大幅上涨后的急剧回调。投资者似乎在进行获利了结，因为该股票最近经历了垂直攀升。</p>
</div><p>The stock surged nearly 72.63% during Monday’s regular trading hours. At the time, the psychedelic sector received a major boost.</p>
<div class="lb-trans"><p>该股票在周一的常规交易时段上涨了近 72.63%。当时，迷幻药行业获得了重大提振。</p>
</div><p>President <strong>Donald Trump</strong> signed an executive order to accelerate mental illness treatments. This order specifically targets faster reviews for psychedelic drugs. It also includes a reported $50 million commitment for ibogaine research.</p>
<div class="lb-trans"><p><strong>唐纳德·特朗普</strong> 总统签署了一项行政命令，以加速 精神疾病治疗。该命令特别针对迷幻药的快速审查，并包括对伊博加因研究的 5000 万美元承诺。</p>
</div><h2>Ibogaine Supply Chain Advantages</h2>
<div class="lb-trans"><h2>伊博加因供应链优势</h2>
</div><p>Psyence Biomedical stands out due to its GMP-compliant ibogaine platform. Through PsyLabs, the company manages sourcing, extraction, and purification in Africa. Psyence is pitching itself as a rare picks-and-shovels supplier. The company already holds stabilized, pharmaceutical-grade ibogaine doses in its current inventory.</p>
<div class="lb-trans"><p>Psyence Biomedical 因其符合 GMP 标准的伊博加因平台而脱颖而出。通过 PsyLabs，该公司在非洲管理原料采购、提取和纯化。Psyence 自我定位为一个稀有的工具和设备供应商。该公司目前已持有稳定的药品级伊博加因剂量。</p>
</div><h2>Psyence Technical Analysis</h2>
<div class="lb-trans"><h2>Psyence 技术分析</h2>
</div><p>PBM is rebounding from its February low but remains well below its 52-week high. The stock is trading 224.7% above its 20-day simple moving average (SMA) and 130.7% above its 100-day SMA.</p>
<div class="lb-trans"><p>PBM 正在从 2 月份的低点反弹，但仍远低于其 52 周高点。该股票交易价格比其 20 日简单移动平均线 (SMA) 高出 224.7%，比其 100 日 SMA 高出 130.7%。</p>
</div><p>The relative strength index (RSI), a momentum gauge, is 96.18.</p>
<div class="lb-trans"><p>相对强弱指数 (RSI) 为 96.18，是一个动量指标。</p>
</div><p>On a longer lens, the stock is down 43.93% over the past 12 months, which keeps the bigger-picture tape fragile despite the recent surge.</p>
<div class="lb-trans"><p>从更长的时间来看，该股票在过去 12 个月内下跌了 43.93%，尽管最近上涨，但整体市场仍显脆弱。</p>
</div><ul>
<li><strong>Key Resistance</strong>: $12.50</li>
<li><strong>Key Support</strong>: $10</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>关键阻力位</strong>：$12.50</li>
<li><strong>关键支撑位</strong>：$10</li>
</ul>
</div><p><strong>PBM Stock Price Activity:</strong> Psyence Biomedical shares were down 3.54% at $10.90 during premarket trading on Tuesday, according to Benzinga Pro data.</p>
<div class="lb-trans"><p><strong>PBM 股票价格动态</strong>：根据 Benzinga Pro 数据，Psyence Biomedical 的股票在周二盘前交易中下跌 3.54%，报$10.90。</p>
</div><p><em>Photo Courtesy: solarseven on Shutterstock.com</em></p>
<div class="lb-trans"><p><em>图片来源：solarseven on Shutterstock.com</em></p>
</div>

为什么 Psyence Biomedical 的股票在周二交易价格较低？